154 related articles for article (PubMed ID: 36261755)
41. Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders.
Mareczek L; Riehl C; Harms M; Reichl S
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297563
[TBL] [Abstract][Full Text] [Related]
42. On the Methods to Measure Powder Flow.
Tan G; Morton DA; Larson I
Curr Pharm Des; 2015; 21(40):5751-65. PubMed ID: 26446467
[TBL] [Abstract][Full Text] [Related]
43. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression.
Chattoraj S; Sun CC
J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737
[TBL] [Abstract][Full Text] [Related]
44. Prediction of granule packing and flow behavior based on particle size and shape analysis.
Sandler N; Wilson D
J Pharm Sci; 2010 Feb; 99(2):958-68. PubMed ID: 19653280
[TBL] [Abstract][Full Text] [Related]
45. Modeling Food Particle Systems: A Review of Current Progress and Challenges.
Fries L
Annu Rev Chem Biomol Eng; 2021 Jun; 12():97-113. PubMed ID: 33770465
[TBL] [Abstract][Full Text] [Related]
46. Process modeling in the pharmaceutical industry using the discrete element method.
Ketterhagen WR; am Ende MT; Hancock BC
J Pharm Sci; 2009 Feb; 98(2):442-70. PubMed ID: 18563797
[TBL] [Abstract][Full Text] [Related]
47. The Application of Modern Powder Characterisation Methods in Product and Process Development of Solid Dosage Forms.
Freeman T; Brockbank K; Armstrong B
Curr Pharm Des; 2015; 21(40):5766-88. PubMed ID: 26446474
[TBL] [Abstract][Full Text] [Related]
48. What is the role of particle morphology in pharmaceutical powder aerosols?
Chan HK
Expert Opin Drug Deliv; 2008 Aug; 5(8):909-14. PubMed ID: 18712999
[TBL] [Abstract][Full Text] [Related]
49. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
[TBL] [Abstract][Full Text] [Related]
50. Modeling and simulation of compact strength due to particle bonding using a hybrid discrete-continuum approach.
Koynov A; Akseli I; Cuitiño AM
Int J Pharm; 2011 Oct; 418(2):273-85. PubMed ID: 21736930
[TBL] [Abstract][Full Text] [Related]
51. Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals - A comprehensive review.
Padrela L; Rodrigues MA; Duarte A; Dias AMA; Braga MEM; de Sousa HC
Adv Drug Deliv Rev; 2018 Jun; 131():22-78. PubMed ID: 30026127
[TBL] [Abstract][Full Text] [Related]
52. Dry Powder Mixing Is Feasible in Continuous Twin Screw Extruder: Towards Lean Extrusion Process for Oral Solid Dosage Manufacturing.
Mateo-Ortiz D; Villanueva-Lopez V; Muddu SV; Doddridge GD; Alhasson D; Dennis MC
AAPS PharmSciTech; 2021 Oct; 22(7):249. PubMed ID: 34648107
[TBL] [Abstract][Full Text] [Related]
53. Three-Dimensional Particle Shape Analysis Using X-ray Computed Tomography: Experimental Procedure and Analysis Algorithms for Metal Powders.
Garboczi EJ; Hrabe N
J Vis Exp; 2020 Dec; (166):. PubMed ID: 33346192
[TBL] [Abstract][Full Text] [Related]
54. Triboelectrification of pharmaceutical powders by particle impact.
Watanabe H; Ghadiri M; Matsuyama T; Ding YL; Pitt KG; Maruyama H; Matsusaka S; Masuda H
Int J Pharm; 2007 Apr; 334(1-2):149-55. PubMed ID: 17141989
[TBL] [Abstract][Full Text] [Related]
55. In-line monitoring and optimization of powder flow in a simulated continuous process using transmission near infrared spectroscopy.
Alam MA; Shi Z; Drennen JK; Anderson CA
Int J Pharm; 2017 Jun; 526(1-2):199-208. PubMed ID: 28445765
[TBL] [Abstract][Full Text] [Related]
56. Mechanical Characterization of Pharmaceutical Powders by Nanoindentation and Correlation with Their Behavior during Grinding.
Baraldi L; De Angelis D; Bosi R; Pennini R; Bassanetti I; Benassi A; Bellazzi GE
Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745719
[TBL] [Abstract][Full Text] [Related]
57. Combining experimental and computational techniques to understand and improve dry powder inhalers.
Chaugule V; Wong CY; Inthavong K; Fletcher DF; Young PM; Soria J; Traini D
Expert Opin Drug Deliv; 2022 Jan; 19(1):59-73. PubMed ID: 34989629
[TBL] [Abstract][Full Text] [Related]
58. Quantitative Microscopy: Particle Size/Shape Characterization, Addressing Common Errors Using 'Analytics Continuum' Approach.
Saravanan D; Muthudoss P; Khullar P; Rose Venis A
J Pharm Sci; 2021 Feb; 110(2):833-849. PubMed ID: 32971124
[TBL] [Abstract][Full Text] [Related]
59. 316L Stainless Steel Powders for Additive Manufacturing: Relationships of Powder Rheology, Size, Size Distribution to Part Properties.
Groarke R; Danilenkoff C; Karam S; McCarthy E; Michel B; Mussatto A; Sloane J; O' Neill A; Raghavendra R; Brabazon D
Materials (Basel); 2020 Dec; 13(23):. PubMed ID: 33291734
[TBL] [Abstract][Full Text] [Related]
60. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
